{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:28:59Z","timestamp":1765960139157},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,2]]},"DOI":"10.7759\/cureus.13088","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T03:31:11Z","timestamp":1612323071000},"source":"Crossref","is-referenced-by-count":9,"title":["Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future"],"prefix":"10.7759","author":[{"given":"Kun","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John N","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Elayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerelda","family":"Esquer Garrigos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad R","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2009.02569.x","article-title":"Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights","volume":"33","author":"Voigt A","year":"2010","unstructured":"Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010, 33:414-419. 10.1111\/j.1540-8159.2009.02569.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192665","article-title":"Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association","volume":"121","author":"Baddour LM","year":"2010","unstructured":"Baddour LM, Epstein AE, Erickson CC, et al.. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010, 121:458-477. 10.1161\/CIRCULATIONAHA.109.192665","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1908355","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"381","author":"Hillock N","year":"2019","unstructured":"Hillock N, Hillock R, Warner M. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019, 381:1895-1905. 10.1056\/NEJMc1908355","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.003929","article-title":"Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large US payer database 1-year post implantation","volume":"9","author":"Sohail MR","year":"2016","unstructured":"Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large US payer database 1-year post implantation. Circ Arrhythm Electrophysiol. 2016, 9:e003929. 10.1161\/CIRCEP.116.003929","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008","volume":"58","author":"Greenspon AJ","year":"2011","unstructured":"Greenspon AJ, Patel JD, Lau E, et al.. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011, 58:1001-1006. 10.1016\/j.jacc.2011.04.033","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009081","article-title":"Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry","volume":"130","author":"Prutkin JM","year":"2014","unstructured":"Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation. 2014, 130:1037-1043. 10.1161\/CIRCULATIONAHA.114.009081","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq497","article-title":"Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients","volume":"32","author":"Johansen JB","year":"2011","unstructured":"Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011, 32:991-998. 10.1093\/eurheartj\/ehq497","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.1540","article-title":"Prevention of cardiac implantable electronic device infections: update and evaluation of the potential role for capsulectomy or the antibiotic pouch","volume":"9","author":"Gleva MJ","year":"2017","unstructured":"Gleva MJ, Poole JE. Prevention of cardiac implantable electronic device infections: update and evaluation of the potential role for capsulectomy or the antibiotic pouch. J Atr Fibrillation. 2017, 9:1540. 10.4022\/jafib.1540","journal-title":"J Atr Fibrillation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1423-5","article-title":"Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections","volume":"49","author":"Sohail MR","year":"2007","unstructured":"Sohail MR, Uslan DZ, Khan AH, et al.. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007, 49:1851-1859. 10.1186\/s12913-016-1423-5","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.108.795906","article-title":"Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial","volume":"2","author":"de Oliveira JC","year":"2009","unstructured":"de Oliveira JC, Martinelli M, Nishioka SA, et al.. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009, 2:29-34. 10.1161\/CIRCEP.108.795906","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810988","article-title":"Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis","volume":"362","author":"Darouiche RO","year":"2010","unstructured":"Darouiche RO, Wall MJ Jr, Itani KM, et al.. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010, 362:18-26. 10.1056\/NEJMoa0810988","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2015.27.2","article-title":"Cardiac implantable electronic device infection in patients at risk","volume":"5","author":"Tarakji KG","year":"2016","unstructured":"Tarakji KG, Ellis CR, Defaye P, Kennergren C. Cardiac implantable electronic device infection in patients at risk. Arrhythm Electrophysiol Rev. 2016, 5:65-71. 10.15420\/aer.2015.27.2","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref13","unstructured":"Huntingdon life sciences study TR-2011-054. (2011)."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182895b8c","article-title":"Gentamicin-collagen implants to reduce surgical site infection: systematic review and meta-analysis of randomized trials","volume":"258","author":"Chang WK","year":"2013","unstructured":"Chang WK, Srinivasa S, MacCormick AD, Hill AG. Gentamicin-collagen implants to reduce surgical site infection: systematic review and meta-analysis of randomized trials. Ann Surg. 2013, 258:59-65. 10.1097\/SLA.0b013e3182895b8c","journal-title":"Ann Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2015.01.034","article-title":"Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: meta-analysis","volume":"149","author":"Kowalewski M","year":"2015","unstructured":"Kowalewski M, Pawliszak W, Zaborowska K, et al.. Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: meta-analysis. J Thorac Cardiovasc Surg. 2015, 149:1631-1640. 10.1016\/j.jtcvs.2015.01.034","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2009.207514","article-title":"Collagen-gentamicin implant for prevention of sternal wound infection; long-term follow-up of effectiveness","volume":"9","author":"Friberg O","year":"2009","unstructured":"Friberg O, Dahlin LG, Kallman J, Kihlstrom E, Soderquist B, Svedjeholm R. Collagen-gentamicin implant for prevention of sternal wound infection; long-term follow-up of effectiveness. Interact Cardiovasc Thorac Surg. 2009, 9:454-458. 10.1510\/icvts.2009.207514","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.06.043","article-title":"Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial","volume":"79","author":"Friberg O","year":"2005","unstructured":"Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005, 79:153-161. 10.1016\/j.athoracsur.2004.06.043","journal-title":"Ann Thorac Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(99)00836-x","article-title":"Adjuvant treatment of deep sternal wound infection with collagenous gentamycin","volume":"68","author":"Leyh RG","year":"1999","unstructured":"Leyh RG, Bartels C, Sievers HH. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann Thorac Surg. 1999, 68:1648-1651. 10.1016\/s0003-4975(99)00836-x","journal-title":"Ann Thorac Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/003655400310000184","article-title":"Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery","volume":"35","author":"Friberg O","year":"2003","unstructured":"Friberg O, Jones I, Sjoberg L, Soderquist B, Vikerfors T, Kallman J. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand J Infect Dis. 2003, 35:251-254. 10.1080\/003655400310000184","journal-title":"Scand J Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12063","article-title":"Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients","volume":"36","author":"Kolek MJ","year":"2013","unstructured":"Kolek MJ, Dresen WF, Wells QS, Ellis CR. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol. 2013, 36:354-361. 10.1111\/pace.12063","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.12.013","article-title":"Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope","volume":"11","author":"Mittal S","year":"2014","unstructured":"Mittal S, Shaw RE, Michel K, et al.. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014, 11:595-601. 10.1016\/j.hrthm.2013.12.013","journal-title":"Heart Rhythm"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.02.016","article-title":"Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the citadel and centurion studies","volume":"3","author":"Henrikson CA","year":"2017","unstructured":"Henrikson CA, Sohail MR, Acosta H, et al.. Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the citadel and centurion studies. JACC Clin Electrophysiol. 2017, 3:1158-1167. 10.1016\/j.jacep.2017.02.016","journal-title":"JACC Clin Electrophysiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jce.13436","article-title":"Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: a meta-analysis","volume":"29","author":"Koerber SM","year":"2018","unstructured":"Koerber SM, Turagam MK, Winterfield J, Gautam S, Gold MR. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: a meta-analysis. J Cardiovasc Electrophysiol. 2018, 29:609-615. 10.1111\/jce.13436","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.02.011","article-title":"The world-wide randomized antibiotic envelope infection prevention (WRAP-IT) trial: long-term follow-up","volume":"17","author":"Mittal S","year":"2020","unstructured":"Mittal S, Wilkoff BL, Kennergren C, et al.. The world-wide randomized antibiotic envelope infection prevention (WRAP-IT) trial: long-term follow-up. Heart Rhythm. 2020, 17:1115-1122. 10.1016\/j.hrthm.2020.02.011","journal-title":"Heart Rhythm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2019.05.003","article-title":"A novel bio envelope and suture orientation for stabilization of the subcutaneous implantable cardioverter defibrillator generator to the chest wall","volume":"4","author":"Xiang K","year":"2019","unstructured":"Xiang K, Levine JS, Elayi SC, Su J, Hsu S, Kim R, Catanzaro JN. A novel bio envelope and suture orientation for stabilization of the subcutaneous implantable cardioverter defibrillator generator to the chest wall. Heart Rhythm Case Reports. 2019, 4:430-432. 10.1016\/j.hrcr.2019.05.003","journal-title":"Heart Rhythm Case Reports"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/pace.13061","article-title":"Enhanced antimicrobial effects of decellularized extracellular matrix (cormatrix) with added vancomycin and gentamicin for device implant protection","volume":"40","author":"Deering TF","year":"2017","unstructured":"Deering TF, Chang C, Snyder C, Natarajan SK, Matheny R. Enhanced antimicrobial effects of decellularized extracellular matrix (cormatrix) with added vancomycin and gentamicin for device implant protection. Pacing Clin Electrophysiol. 2017, 40:615-623. 10.1111\/pace.13061","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/pace.13888","article-title":"Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope","volume":"43","author":"Sohail MR","year":"2020","unstructured":"Sohail MR, Esquer Garrigos Z, Elayi CS, Xiang K, Catanzaro JN. Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope. Pacing Clin Electrophysiol. 2020, 43:341-349. 10.1111\/pace.13888","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10029-013-1070-2","article-title":"Remodeling characteristics and biomechanical properties of a crosslinked versus a non-crosslinked porcine dermis scaffolds in a porcine model of ventral hernia repair","volume":"19","author":"Cavallo JA","year":"2015","unstructured":"Cavallo JA, Greco SC, Liu J, Frisella MM, Deeken CR, Matthews BD. Remodeling characteristics and biomechanical properties of a crosslinked versus a non-crosslinked porcine dermis scaffolds in a porcine model of ventral hernia repair. Hernia. 2015, 19:207-218. 10.1007\/s10029-013-1070-2","journal-title":"Hernia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.10.048","article-title":"In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model","volume":"148","author":"Fallon AM","year":"2014","unstructured":"Fallon AM, Goodchild TT, Cox JL, Matheny RG. In vivo remodeling potential of a novel bioprosthetic tricuspid valve in an ovine model. J Thorac Cardiovasc Surg. 2014, 148:333-340. 10.1016\/j.jtcvs.2013.10.048","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEA.2010.0188","article-title":"Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells","volume":"17","author":"Tottey S","year":"2011","unstructured":"Tottey S, Corselli M, Jeffries EM, Londono R, Peault B, Badylak SF. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A. 2011, 17:37-44. 10.1089\/ten.TEA.2010.0188","journal-title":"Tissue Eng Part A"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.34671.","article-title":"Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body response","volume":"102","author":"Wolf MT","year":"2014","unstructured":"Wolf MT, Carruthers CA, Dearth CL, et al.. Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body response. J Biomed Mater Res A. 2014, 102:234-246. 10.1002\/jbm.a.34671.","journal-title":"J Biomed Mater Res A"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.10062","article-title":"Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair","volume":"67","author":"Badylak SF","year":"2003","unstructured":"Badylak SF, Wu CC, Bible M, McPherson E. Host protection against deliberate bacterial contamination of an extracellular matrix bioscaffold versus Dacron mesh in a dog model of orthopedic soft tissue repair. J Biomed Mater Res B Appl Biomater. 2003, 67:648-654. 10.1002\/jbm.b.10062","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1089\/ten.2006.12.2949","article-title":"Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix","volume":"12","author":"Brennan EP","year":"2006","unstructured":"Brennan EP, Reing J, Chew D, Myers-Irvin JM, Young EJ, Badylak SF. Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng. 2006, 12:2949-2955. 10.1089\/ten.2006.12.2949","journal-title":"Tissue Eng"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani A","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013, 229:176-185. 10.1002\/path.4133","journal-title":"J Pathol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903356","article-title":"Differential roles of macrophages in diverse phases of skin repair","volume":"184","author":"Lucas T","year":"2010","unstructured":"Lucas T, Waisman A, Ranjan R, et al.. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010, 184:3964-3977.  10.4049\/jimmunol.0903356","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2011.11.031","article-title":"Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials","volume":"8","author":"Brown BN","year":"2012","unstructured":"Brown BN, Londono R, Tottey S, et al.. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater. 2012, 8:978-987. 10.1016\/j.actbio.2011.11.031","journal-title":"Acta Biomater"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEB.2014.0290","article-title":"To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices","volume":"21","author":"Delgado LM","year":"2015","unstructured":"Delgado LM, Bayon Y, Pandit A, Zeugolis DI. To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices. Tissue Eng Part B Rev. 2015, 21:298-313. 10.1089\/ten.TEB.2014.0290","journal-title":"Tissue Eng Part B Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2014.06.021","article-title":"Outcomes of abdominal wall reconstruction with acellular dermal matrix are not affected by wound contamination","volume":"219","author":"Garvey PB","year":"2014","unstructured":"Garvey PB, Martinez RA, Baumann DP, Liu J, Butler CE. Outcomes of abdominal wall reconstruction with acellular dermal matrix are not affected by wound contamination. J Am Coll Surg. 2014, 219:853-864. 10.1016\/j.jamcollsurg.2014.06.021","journal-title":"J Am Coll Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00360","article-title":"Microbiological characteristics and clinical features of cardiac implantable electronic device infections at a tertiary hospital in China","volume":"8","author":"Wang R","year":"2017","unstructured":"Wang R, Li X, Wang Q, Zhang Y, Wang H. Microbiological characteristics and clinical features of cardiac implantable electronic device infections at a tertiary hospital in China. Front Microbiol. 2017, 8:360. 10.3389\/fmicb.2017.00360","journal-title":"Front Microbiol"},{"key":"ref40","article-title":"Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms","volume":"135","author":"Gomes F","year":"2012","unstructured":"Gomes F, Teixeira P, Ceri H, Oliveira R. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms. Indian J Med Res. 2012, 135:542-547.","journal-title":"Indian J Med Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00922-07","article-title":"Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model","volume":"52","author":"Bowker KE","year":"2008","unstructured":"Bowker KE, Noel AR, Macgowan AP. Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 2008, 52:4370-4373. 10.1128\/AAC.00922-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24155","article-title":"Topical rifampin powder for orthopaedic trauma part II: Topical rifampin allows for spontaneous bone healing in sterile and contaminated wounds","volume":"36","author":"Shiels SM","year":"2018","unstructured":"Shiels SM, Tennent DJ, Lofgren AL, Wenke JC. Topical rifampin powder for orthopaedic trauma part II: Topical rifampin allows for spontaneous bone healing in sterile and contaminated wounds. J Orthop Res. 2018, 36:3142-3150. 10.1002\/jor.24155","journal-title":"J Orthop Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/cc12608","article-title":"Clinical review: efficacy of antimicrobial-impregnated catheters in external ventricular drainage - a systematic review and meta-analysis","volume":"17","author":"Wang X","year":"2013","unstructured":"Wang X, Dong Y, Qi XQ, Li YM, Huang CG, Hou LJ. Clinical review: efficacy of antimicrobial-impregnated catheters in external ventricular drainage - a systematic review and meta-analysis. Crit Care. 2013, 17:234. 10.1186\/cc12608","journal-title":"Crit Care"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2009.08.007","article-title":"The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2","volume":"14","author":"Chemaly RF","year":"2010","unstructured":"Chemaly RF, Sharma PS, Youssef S, et al.. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis. 2010, 14:548-552. 10.1016\/j.ijid.2009.08.007","journal-title":"Int J Infect Dis"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl522","article-title":"Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials","volume":"59","author":"Falagas ME","year":"2007","unstructured":"Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007, 59:359-369. 10.1093\/jac\/dkl522","journal-title":"J Antimicrob Chemother"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2009.02406.x","article-title":"In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices","volume":"32","author":"Hansen LK","year":"2009","unstructured":"Hansen LK, Brown M, Johnson D, Palme Ii DF, Love C, Darouiche R. In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices. Pacing Clin Electrophysiol. 2009, 32:898-907. 10.1111\/j.1540-8159.2009.02406.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-603","article-title":"Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumption","volume":"7","author":"Stokkou S","year":"2014","unstructured":"Stokkou S, Tammer I, Zibolka S, Grabau C, Geginat G. Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumption. BMC Res Notes. 2014, 7:603. 10.1186\/1756-0500-7-603","journal-title":"BMC Res Notes"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky087","article-title":"Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms","volume":"73","author":"Dall GF","year":"2018","unstructured":"Dall GF, Tsang SJ, Gwynne PJ, et al.. Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms. J Antimicrob Chemother. 2018, 73:1830-1840. 10.1093\/jac\/dky087","journal-title":"J Antimicrob Chemother"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl216","article-title":"Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM)","volume":"58","author":"Schafer JA","year":"2006","unstructured":"Schafer JA, Hovde LB, Rotschafer JC. Consistent rates of kill of Staphylococcus aureus by gentamicin over a 6-fold clinical concentration range in an in vitro pharmacodynamic model (IVPDM). J Antimicrob Chemother. 2006, 58:108-111. 10.1093\/jac\/dkl216","journal-title":"J Antimicrob Chemother"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/eux158.123","article-title":"Zero device-related infections in 4285 patient-years of follow-up after cardiac implantable electronic device replacement combined with topic gentamicin-collagen sponge application","volume":"19","author":"Futyma PR","year":"2017","unstructured":"Futyma PR, Gluszczyk R, Ciapala K, Futyma M. Zero device-related infections in 4285 patient-years of follow-up after cardiac implantable electronic device replacement combined with topic gentamicin-collagen sponge application. EP Europace. 2017, 19:306. 10.1093\/ehjci\/eux158.123","journal-title":"EP Europace"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45060-antibiotic-eluting-envelopes-to-prevent-cardiac-implantable-electronic-device-infection-past-present-and-future","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:36Z","timestamp":1707507216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45060-antibiotic-eluting-envelopes-to-prevent-cardiac-implantable-electronic-device-infection-past-present-and-future"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.13088","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,2]]}}}